Growing evidence suggests that cytokine expression is influenced by locally produced medWtors, thus modiing the phlripotential effects of cytokines toward a tissue-specific inflammatory reaction. The granulocyte inhibitory protein (GIP), a 23-kDa protein found to be s fcantly overexpressed in patients with chronic renal failure, increases autocrine transcription and expression ofinterleukin (IL) 6 and IL-8 in human mesangial cells. Moreover, GIP alone induced the btanscription of c-jun mRNA; however, in combination with IL-6, it stimulated de novo synthesis of DNA and the tanscription of both c-jun and c-fos genes. The data suggest that the overall effect of GIP results in the modulation of the glomerular response to ijury and contributes to the progression of glomeruloscleross.
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Increased proliferation of mesangial cells (MCs) and expansion ofthe.extracellular mesangial matrix are striking features of acute and progressive glomerular disease in humans regardless of the primary stimulus (1) . MCs play an important role in the modulation of glomerular injury since they produce and react to numerous inflammatory mediators, including platelet-derived growth factor (2, 3) , interleukin (IL) 6 (4-6), and IL-8 (7) . Overexpression of IL-6, IL-8, and extracellular matrix proteins are characteristic features associated with glomerular inflammation in humans (8) (9) (10) . While extracellular matrix proteins have an impact on cell functions such as adherence, growth, and secretion or deposition of cellular products, IL-6 serves to regulate the immune response, acute phase reactions, and hematopoiesis (11, 12) . is capable of activating and eliciting selective diapedesis of polymorphonuclear leukocytes (PMNs), which participate in the development of glomerulonephritis (13) .
We have recently characterized a granulocyte inhibitory protein (GIP) from the ultrafiltrate of patients with renal failure that blocked chemotaxis, 14C-labeled hexose uptake, and intracellular killing of bacteria in PMNs (14) . GIP cDNA (American Type Culture Collection) in pGEM2 containing 452 nt of the original sequence including the T7 RNA polymerase promoter. In vitro transcription and labeling was performed with Escherichia coli DNA-dependent 17 polymerase (Boehringer Mannheim) in a 10-A4 reaction at 37°C for 60 min followed by gel purification of the RNA probe in a 6% urea/SDS/acrylamide gel. The labeled probe was eluted overnight at 37°C in a solution containing 2 M NH4CH3-COOH, 1% SDS, and 0.1% EDTA (pH 7.5) plus 20 ,g of tRNA, precipitated with 100% ethanol (30 min, -70°C), and redissolved in 80%o (vol/vol) formamide hybridization buffer. For each test sample, 10 p,g of total MC RNA or 10 ,g of RNase-free yeast tRNA as specificity control was precipitated, redissolved in 30 p1 of hybridization buffer containing 90,000 cpm/yl, and incubated for 12 hr at 50°C. Nonhybridized RNA was then digested with RNase T1 (10 ,g/ml) (Boehringer Mannheim) for 1 hr at 30°C. The reaction was stopped by addition of 5 M guanidium isothiocyanate/l M sodium citrate/20% sarkosyl; the RNA was then again phenol extracted and finally precipitated with 2 M sodium acetate at pH 4.5, and tRNA (25 yg final) was stored in 100% isopropyl alcohol at -20°C. After washing in 70%o ethanol and a 3-hr separation in a 6% urea/1% SDS/acrylamide gel (300 V), the hybridized RNA was visualized by exposure of the dried gel to x-ray film (X-Omat AR; Kodak) for 2 days at -70°C.
Protein Expression of IL-6 and IL-8. Human MCs were grown to subconfluence, synchronized as described above, and challenged with IL-6 (1 nM) with and without GIP (10 ,ug/ml) for 1 hr, followed by exchange of medium to replace the stimulating agents, and an additional incubation for 6 (5, 20) . To examine the mechanism by which GIP augments the expression of IL-6, we tested the effect of the peptide on autocrine secretion of IL-6 in human MCs. In the absence of IL-6, GIP induced the transcription of IL-6 mRNA by a factor of 2 above basal level (Fig. 2) . The transcription started to increase at 3 hr, peaked at 6 hr, and declined thereafter to basal level. This effect was similar to that induced by the addition of exogenous IL-6. However, the combination of both agents resulted in markedly increased expression of IL-6 mRNA that was about 5-fold greater than that achieved by either substance.
It has been demonstrated that IL-6 not only stimulates autocrine secretion of IL-6 but also induces transcription and translation of Taking into account that the induction of IL-6 mRNA is amplified by GIP, we hypothesized that the peptide should also influence the transcription of IL-8 mRNA. Therefore, we next examined the ability of GIP to induce IL-8 mRNA. As depicted in Fig. 3 (Fig. 4) . When testing the effects as a function of increasing dosage ofGIP (2.5-10 ,ug/ml) in the presence offixed concentrations of IL-6 (1 nM), there was a dose-dependent increase in gene transcription (data not shown). The effects of all substances on the IL-6 and IL-8 genes were abolished by pretreatment of MCs with actinomycin D (5 pg/ml, 30 min), an inhibitor of RNA synthesis, which suggests that the changes occurred at the mRNA level.
Effect of GIP on Tra ption of c-jun and c-fos mRNAs. The activation of the gene encoding involves, at least in part, the formation of the AP-1 or c-fos (serum responsive element) transcription factor (21) . Since GIP modulated the transcription and expression of IL-6, we studied its effect on transcription of c-jun and c-fos mRNAs, both of which constitute the AP-1 transcription factor. Fig. SA illustrates the effect of and GIP on the transcription of c-jun; in contrast to IL-6, GIP alone induced an increase in c-jun mRNA whereas c-fos was only marginally transcribed (Fig.  SB) . However, the simultaneous presence of the peptide and exogenotfs IL-6 markedly amplified the transcription of both early response genes.
DISCUSSION
Nanomolar concentrations of GIP induced the transcription and expression of IL-6 and IL-8, both of which are involved in the formation of synechiae or crescents and in tubulointerstitial and glomerular injury. Studies on the mechanism of gene transcription indicate a specific ability of GIP to modulate the transcription of c-jun and c-fos.
We have previously shown that GIP, at concentrations that can be obtained under clinical circumstances, is capable of inhibiting effector cell functions of cell-mediated immunity, which could, at least in part, explain the increased susceptibility to infections frequently found in patiepts with chronic renal failure (14) . The consequences of our present finding, gene expression has been implicated in the pathogenesis of autoimmune diseases and plasma cell neoplasias (22) (23) (24) . In fact, IL-6transgenic C57BL/6 mice showed a massive polyclonal plasmacytosis with production of autoantibodies and mesangial proliferative glomerulonephritis (25) . Our observation that GIP, a peptide that is overexpressed in chronic renal disease, amplifies the autocrine effect of IL-6 could delineate a mechanism by which glomerular damage may persist after an initial injury and result in progressive glomerular sclerosis. IL-8 is thought to act as the major stimulus for glomervlar recruitment of inflammatory cells such as PMNs. In addition to IL-6, IL-la, tumor necrosis factor, or lipopolysaccharide stimulated the transcription and expression of IL-8 in MCs. Infusion of the latter cytokines increased the severity of glomerular injury in a PMN-dependent model of glomerulonephritis (7). The fact that GIP, either alone or in combination with IL-6, augmented the transcription and expression of IL-8 gene suggests a potential paracrine function of the peptide to initiate and sustain inflammatory lesions associated with glomerular injury.
What could be the mechanism of action by which GIP stimulates expression of IL-6 and IL-8? (i) IL-6 acts by binding to its receptor, which consists of two molecules: a ligand-binding 80-kDa or a non-ligand-binding transducer, gpl30, both of which belong to the cytokine family (26, 27) . Thus, GIP could facilitate the binding of IL-6 to either receptor site (by heterologous regulation), leading to intensification of transcription ofIL-6 mRNA. (ii) Our observation that GIP induced c-jun, and also c-fos in combination with exogenous IL-6, agrees with the notion that activation of transcription of IL-6 gene involves Fos and Jun (28) . Analogously, prolonged transcription of c-jun and c-fos has been found in the phase of cell proliferation and differentiation after tissue injury (29) . (iii) A nuclear factor responsible for IL-6 expression, NF-IL-6, was shown to bind to the regulatory regions of various acute-phase proteins and cytokines such as . Consequently, a GIP-dependent increase of transcription of IL-6 would result in an increased transcription of IL-8 mRNA. The presence of GIP could, therefore, exaggerate MC responses to inflammatory stimuli by activating autocrine secretion of IL-6 and IL-6-dependent induction of IL-8.
Beyond the scope of these investigations, an exact characterization of the role of GIP for the pathogenesis of inflammatory mechanisms of the kidney requires the cloning of its complete gene.
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